Results 11 to 20 of about 285,624 (259)

Age-related macular degeneration

open access: yesCommunity Eye Health Journal, 2014
Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among people aged 50 and older in ...
Wanjiku Mathenge
doaj   +1 more source

Age-related macular degeneration

open access: yesClinical Ophthalmology, 2011
Giuseppe Querques¹, Fernando Onofrio Avellis1,2, Lea Querques1,3, Francesco Bandello³, Eric H Souied¹ ¹Service d'Ophtalmologie, Centre Hospitalier Intercommunal Créteil, Université Paris ...
Querques G   +4 more
doaj   +1 more source

Modelling the Genetic Risk in Age-Related Macular Degeneration [PDF]

open access: yes, 2012
Late-stage age-related macular degeneration (AMD) is a common sight-threatening disease of the central retina affecting approximately 1 in 30 Caucasians.
Weber, Bernhard H. F.   +29 more
core   +1 more source

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration [PDF]

open access: yes, 2009
To describe the 2- to 4-year visual and microperimetry outcomes of autologous retinal pigment epithelium (RPE)-choroid graft in patients with neovascular age-related macular degeneration (AMD).In this retrospective cohort study, 12 patients with ...
Coffey, PJ   +9 more
core   +1 more source

Candidate gene study of macular response to supplemental lutein and zeaxanthin. [PDF]

open access: yes, 2013
Supplementation with carotenoids is proposed to protect against age-related macular degeneration. There is, however, considerable variability in retinal macular pigment response, which may be due to underlying genetic variation. The purpose of this study
Liew, SH Melissa   +15 more
core   +1 more source

mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV

open access: yesCell Communication and Signaling, 2019
Background The mechanistic target of rapamycin (mTOR) pathway is a potential target to inhibit pathologic processes in choroidal neovascularization. However, the exact role of mTOR signaling in the development of CNV remains obscure.
Jin Young Yang   +7 more
doaj   +1 more source

The estimated prevalence and incidence of late stage age related macular degeneration in the UK [PDF]

open access: yes, 2012
BACKGROUND: UK estimates of age related macular degeneration (AMD) occurrence vary. AIMS: To estimate prevalence, number and incidence of AMD by type in the UK population aged ≥50 years.
Fletcher, AE   +11 more
core   +1 more source

Dual Sensory Impairment: The Correlation between Age Related Macular Degeneration and Sensorineural Hearing Loss

open access: yesMedicina, 2022
The pathogeneses of age-related macular degeneration (AMD) and age-related hearing impairment are not yet fully understood. If AMD and age-related hearing impairment are correlated, the cause of both may be a result of a common vulnerability.
Marina Istrate   +5 more
doaj   +1 more source

Open innovation in neuroscience research and drug discovery

open access: yesBrain and Neuroscience Advances, 2018
The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation.
Ann J. Hunter, Wen H. Lee, Chas Bountra
doaj   +1 more source

Novel rodent models for macular research [PDF]

open access: yes, 2010
BACKGROUND: Many disabling human retinal disorders involve the central retina, particularly the macula. However, the commonly used rodent models in research, mouse and rat, do not possess a macula.
Gesine Huber   +53 more
core   +2 more sources

Home - About - Disclaimer - Privacy